Jasper Therapeutics, Inc. (JSPR)
NASDAQ: JSPR · Real-Time Price · USD
4.300
-0.160 (-3.59%)
At close: Mar 31, 2025, 4:00 PM
4.454
+0.154 (3.59%)
After-hours: Mar 31, 2025, 7:29 PM EDT
Jasper Therapeutics Market Cap
Jasper Therapeutics has a market cap or net worth of $64.60 million as of March 31, 2025. Its market cap has decreased by -83.99% in one year.
Market Cap
64.60M
Enterprise Value
-5.23M
1-Year Change
-83.99%
Ranking
Category
Stock Price
$4.30
Market Cap Chart
Since January 10, 2020, Jasper Therapeutics's market cap has decreased from $122.75M to $64.60M, a decrease of -47.38%. That is a compound annual growth rate of -11.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 67.00M | -79.11% |
| Dec 31, 2024 | 320.73M | 264.33% |
| Dec 29, 2023 | 88.03M | 294.73% |
| Dec 30, 2022 | 22.30M | -94.26% |
| Dec 31, 2021 | 388.71M | 210.66% |
| Dec 31, 2020 | 125.13M | 1.93% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |